Hillhouse Capital Management, Ltd. - Net Worth and Insider Trading

Hillhouse Capital Management, Ltd. Net Worth

The estimated net worth of Hillhouse Capital Management, Ltd. is at least $1.4 Billion dollars as of 2024-06-22. Hillhouse Capital Management, Ltd. is the 2102 Investment manager of Genscript Biotech Corp and owns about 164,770,965 shares of Genscript Biotech Corp (HKSE:01548) stock worth over $1.4 Billion. Details can be seen in Hillhouse Capital Management, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hillhouse Capital Management, Ltd. has not made any transactions after 2021-06-10 and currently still holds the listed stock(s).

Transaction Summary of Hillhouse Capital Management, Ltd.

Hillhouse Capital Management, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hillhouse Capital Management, Ltd. owns 1 companies in total, including Genscript Biotech Corp (HKSE:01548) .

Click here to see the complete history of Hillhouse Capital Management, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Hillhouse Capital Management, Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:01548	Genscript Biotech Corp	2021-06-10	2102 Investment manager

Hillhouse Capital Management, Ltd. Latest Holdings Summary

Hillhouse Capital Management, Ltd. currently owns a total of 1 stock. Hillhouse Capital Management, Ltd. owns 164,770,965 shares of Genscript Biotech Corp (HKSE:01548) as of June 10, 2021, with a value of $1.4 Billion.

Latest Holdings of Hillhouse Capital Management, Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01548	Genscript Biotech Corp	2021-06-10	164,770,965	8.49	1,398,905,493

Holding Weightings of Hillhouse Capital Management, Ltd.

Hillhouse Capital Management, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Hillhouse Capital Management, Ltd. has made a total of 1 transactions in Genscript Biotech Corp (HKSE:01548) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Genscript Biotech Corp is the sale of 0 shares on June 10, 2021, which brought Hillhouse Capital Management, Ltd. around $0.

Insider Trading History of Hillhouse Capital Management, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hillhouse Capital Management, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hillhouse Capital Management, Ltd. Ownership Network

Ownership Network List of Hillhouse Capital Management, Ltd.

No Data

Ownership Network Relation of Hillhouse Capital Management, Ltd.

Hillhouse Capital Management, Ltd. Owned Company Details

What does Genscript Biotech Corp do?

Who are the key executives at Genscript Biotech Corp?

Hillhouse Capital Management, Ltd. is the 2102 Investment manager of Genscript Biotech Corp. Other key executives at Genscript Biotech Corp include 2401 A concert party to an agreement to buy shares Wang Luquan , 2101 Beneficial owner Wang Ye , and 2401 A concert party to an agreement to buy shares Zhang Fangliang .

Genscript Biotech Corp (HKSE:01548) Insider Trades Summary

Over the past 18 months, Hillhouse Capital Management, Ltd. made no insider transaction in Genscript Biotech Corp (HKSE:01548). Other recent insider transactions involving Genscript Biotech Corp (HKSE:01548) include a net sale of 0 shares made by Zhang Fangliang , a net sale of 0 shares made by Wang Ye , and a net sale of 0 shares made by Wang Luquan .

In summary, during the past 3 months, insiders sold 0 shares of Genscript Biotech Corp (HKSE:01548) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,156,000 shares of Genscript Biotech Corp (HKSE:01548) were sold and 25,734,000 shares were bought by its insiders, resulting in a net purchase of 8,578,000 shares.

Genscript Biotech Corp (HKSE:01548)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genscript Biotech Corp Insider Transactions

No Available Data

Hillhouse Capital Management, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Hillhouse Capital Management, Ltd.. Currently GuruFocus does not have mailing address information for Hillhouse Capital Management, Ltd..

Discussions on Hillhouse Capital Management, Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.